Fig. 1: Calculation of EASIX score, composite risk model and survival outcomes in patients with CMML undergoing alloSCT.

a Time period for calculation of EASIX scores. b Relapse incidence in patients with CMML stratified by CPSS cytogenetic risk. c EASIX-CPSSc based composite risk model. d Survival outcomes stratified by EASIX-CPSSc composite risk model. e Multivariate analysis for 3-year survival after allogeneic transplant.